TREATMENT OF IRON OVERLOAD IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS.

Tim E. Taber, Theodore F. Hegeman, Rosalind Miller, Susan York

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

A number of side effects of uremia have become significant due to the increased life expectancy brought about by the success of dialytic support for end-stage renal disease (ESRD). Anemia, of multifactorial etiology, is symptomatically one of the most significant; often it is treated only with transfusions. These transfusions eventually may be associated with iron overload, or 'transfusional hemosiderosis,' in the ESRD population. In a transfusion-dependent ESRD patient, the only viable treatment for this iron overload has been chelation with deferoxamine (DFO), used for this purpose. Intraperitoneal (IP) administration of DFO has been used and published in case studies. This paper reports on a study to establish the potential for removal of iron via a protocol avoiding multiple daily continuous ambulatory dialysis patients bag manipulations. Study methods and results are discussed.

Original languageEnglish (US)
Pages (from-to)654-656
Number of pages3
JournalASAIO Transactions
Volume33
Issue number3
StatePublished - Jul 1 1987
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics

Fingerprint Dive into the research topics of 'TREATMENT OF IRON OVERLOAD IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS.'. Together they form a unique fingerprint.

  • Cite this

    Taber, T. E., Hegeman, T. F., Miller, R., & York, S. (1987). TREATMENT OF IRON OVERLOAD IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS. ASAIO Transactions, 33(3), 654-656.